StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories u.S. FDA Premarket Approvals (PMA) — Total U.S. MedTech Industry

U.S. FDA openFDA PMA Database

QuarterlyAnnualMonthly
Latest, Sep 2026
187
Period ended Sep 30, 2026
Change on a year earlier
-7.0%
201 in Sep 2025
History
153 months
Since Jan 2014
Sources
1
U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR

Monthly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. FDA Premarket Approvals (PMA) — Total U.S. MedTech IndustryYear on yearSource
Sep 2026Sep 30, 2026187-7.0%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Aug 2026Aug 31, 2026160-13.5%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Jul 2026Jul 31, 2026218+9.5%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Jun 2026Jun 30, 2026185-15.5%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
May 2026May 31, 2026213+19.0%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Apr 2026Apr 30, 2026210+10.5%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Mar 2026Mar 31, 20261780.0%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Feb 2026Feb 28, 2026253+29.1%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Jan 2026Jan 31, 2026136-9.3%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Dec 2025Dec 31, 2025218-9.5%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Nov 2025Nov 30, 202580-63.0%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Oct 2025Oct 31, 2025227+0.4%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Sep 2025Sep 30, 2025201+14.9%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Aug 2025Aug 31, 2025185+10.1%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Jul 2025Jul 31, 2025199+2.1%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Jun 2025Jun 30, 2025219+28.1%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗

Cite this data

StockData. (2026). Abbott Laboratories U.S. FDA Premarket Approvals (PMA) — Total U.S. MedTech Industry, monthly Jan 2014–Sep 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ext-fda-pma-ind

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.